Clin B, Gramond C, Delva F, Andujar P, Thaon I, Brochard P
BMC Public Health. 2025; 25(1):686.
PMID: 39972315
PMC: 11841182.
DOI: 10.1186/s12889-025-21969-0.
Porzio A, Feola A, Salzillo C, Corbi G, Campobasso C
Healthcare (Basel). 2024; 12(18).
PMID: 39337157
PMC: 11431736.
DOI: 10.3390/healthcare12181816.
Jarvholm B, Burdorf A
Scand J Work Environ Health. 2024; 50(2):53-60.
PMID: 38323897
PMC: 10924740.
DOI: 10.5271/sjweh.4146.
Porzio A, Feola A, Parisi G, Lauro A, Campobasso C
Healthcare (Basel). 2023; 11(23).
PMID: 38063645
PMC: 10705936.
DOI: 10.3390/healthcare11233077.
Rom W, Rao A, Hoepner L, Dickey C
Int J Environ Res Public Health. 2023; 20(12).
PMID: 37372732
PMC: 10297959.
DOI: 10.3390/ijerph20126146.
Mesothelioma Risk among Construction Workers According to Job Title: Data from the Italian Mesothelioma Register.
Vimercati L, Cavone D, De Maria L, Caputi A, Pentimone F, Sponselli S
Med Lav. 2023; 114(3):e2023025.
PMID: 37309879
PMC: 10281067.
DOI: 10.23749/mdl.v114i3.14538.
Treatment of Patients with Malignant Peritoneal Mesothelioma.
Li C, Kennedy T, Alexander H
J Clin Med. 2022; 11(7).
PMID: 35407498
PMC: 8999919.
DOI: 10.3390/jcm11071891.
Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
Serio G, Pezzuto F, Fortarezza F, Marzullo A, Delfino M, dAmati A
Int J Mol Sci. 2022; 23(5).
PMID: 35269773
PMC: 8910028.
DOI: 10.3390/ijms23052630.
A Real-World Analysis of the Use of Systemic Therapy in Malignant Pleural Mesothelioma and the Differential Impacts on Overall Survival by Practice Pattern.
Kerrigan K, Jo Y, Chipman J, Haaland B, Puri S, Akerley W
JTO Clin Res Rep. 2022; 3(3):100280.
PMID: 35243411
PMC: 8861643.
DOI: 10.1016/j.jtocrr.2022.100280.
The Use of Immunohistochemistry, Fluorescence Hybridization, and Emerging Epigenetic Markers in the Diagnosis of Malignant Pleural Mesothelioma (MPM): A Review.
Rozitis E, Johnson B, Cheng Y, Lee K
Front Oncol. 2020; 10:1742.
PMID: 33014860
PMC: 7509088.
DOI: 10.3389/fonc.2020.01742.
Lung cancer screening, what has changed after the latest evidence?.
Trujillo-Reyes J, Seijo L, Martinez-Tellez E, Counago F
World J Radiol. 2020; 12(7):130-136.
PMID: 32850015
PMC: 7422527.
DOI: 10.4329/wjr.v12.i7.130.
Gender Differences in Outcomes of Patients With Mesothelioma.
Alpert N, van Gerwen M, Flores R, Taioli E
Am J Clin Oncol. 2020; 43(11):792-797.
PMID: 32815857
PMC: 7584743.
DOI: 10.1097/COC.0000000000000745.
Global use of asbestos - legitimate and illegitimate issues.
Frank A
J Occup Med Toxicol. 2020; 15:16.
PMID: 32549902
PMC: 7294762.
DOI: 10.1186/s12995-020-00267-y.
Epidemiology of mesothelioma in the 21 century in Europe and the United States, 40 years after restricted/banned asbestos use.
Alpert N, van Gerwen M, Taioli E
Transl Lung Cancer Res. 2020; 9(Suppl 1):S28-S38.
PMID: 32206568
PMC: 7082259.
DOI: 10.21037/tlcr.2019.11.11.
Radiographic Changes in Colombian Asbestos Factory Workers.
Frank A, Villamizar G, Bustillo Pereira J
Ann Glob Health. 2020; 86(1):3.
PMID: 31934550
PMC: 6952967.
DOI: 10.5334/aogh.2634.
Asbestos-related pleural disease.
Geller S, Campos F
Autops Case Rep. 2019; 3(2):59-61.
PMID: 31528609
PMC: 6673680.
DOI: 10.4322/acr.2013.019.
Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA.
Keshava H, Tang A, Siddiqui H, Raja S, Raymond D, Bribriesco A
World J Surg. 2019; 43(12):3239-3247.
PMID: 31428834
DOI: 10.1007/s00268-019-05132-6.
Epidemiological science and cancer control.
Toporcov T, Wunsch Filho V
Clinics (Sao Paulo). 2018; 73(suppl 1):e627s.
PMID: 30281702
PMC: 6142858.
DOI: 10.6061/clinics/2018/e627s.
Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation.
Baur X
Int J Environ Res Public Health. 2018; 15(1).
PMID: 29337930
PMC: 5800242.
DOI: 10.3390/ijerph15010143.
Toward an Asbestos Ban in the United States.
Lemen R, Landrigan P
Int J Environ Res Public Health. 2017; 14(11).
PMID: 29072598
PMC: 5707941.
DOI: 10.3390/ijerph14111302.
